前收市價 | 6.50 |
開市 | 6.50 |
買盤 | 4.50 |
賣出價 | 9.40 |
拍板 | 15.00 |
到期日 | 2024-06-21 |
今日波幅 | 6.50 - 6.50 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 101 |
New data indicate that its cell therapy could soon find a larger market.
Iovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its combination therapy achieved an objective response rate of 65% in frontline advanced melanoma.
These biotech stocks have just launched their first products.